MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Results
ROCKVILLE, Md., Jan. 08, 2024 -- MaxCyte, Inc., , a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of...